Skip to main content

Advertisement

SpringerLink
Log in

Insights into current directions of protein and peptide-based hydrogel drug delivery systems for inflammation

  • Review Paper
  • Published:
Polymer Bulletin Aims and scope Submit manuscript

Abstract

An immune system responds to pathogens, toxic compounds, or certain physiological conditions which lead to inflammation. However, uncontrolled and excessive inflammation is associated with a variety of severe chronic conditions including intestinal disorders, cancer, diabetes, and myocardial infarction. The development of anti-inflammatory therapies to treat and manage relevant chronic diseases has resulted from a better understanding of inflammation. However, clinical outcomes vary among patients and serious adverse effects are often observed. Furthermore, clinical anti-inflammatory therapeutics have some limitations due to their insolubility in water, low bioavailability, and poor accessibility to subcellular compartments. To address these challenges, the drug delivery system specific to inflammation offers significant potential. A hydrogel is attractive as a drug delivery platform because of its outstanding characteristics, including swellability, biocompatibility, controlled degradation, and sustained drug release. Hydrogels have been widely used in biomedical applications for several reasons, using diverse polymers of synthetic and natural origin. The design of hydrogels relies heavily on proteins and peptides because proteins are the fundamental macromolecules in living organisms for biochemical, mechanical, and structural functions. Therefore, they provide us with a wide range of structural building blocks for the formation of various types of biomaterials, including hydrogels. Since natural proteins and peptides are biocompatible and biodegradable, they have features advantageous for their use as the building blocks of hydrogels for biomedical applications. This review aims to focus on hydrogels derived from protein and peptide-based systems and highlights recent trends in the use of protein and peptide-based hydrogels as drug delivery systems for inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability statement

The raw/processed data required to reproduce these findings cannot be shared at this time as the data also form part of our future research study.

References

  1. Chovatiya R, Medzhitov R (2014) Stress, inflammation, and defense of homeostasis. Mol Cell 54(2):281–288. https://doi.org/10.1016/j.molcel.2014.03.030

  2. Zhou Y, Hong Y, Huang H (2016) Triptolide Attenuates inflammatory response in membranous glomerulo-nephritis rat via downregulation of NF-κB signaling pathway. Kidney Blood Press Res 41(6):901–910. https://doi.org/10.1159/000452591

  3. Li J, Mooney DJ (2016) Designing hydrogels for controlled drug delivery. Nat Rev Mater 1(12). 10.1038/natrevmats.2016.71

  4. Bahram M, Mohseni N, Moghtader M (2016) An introduction to hydrogels and some recent applications. In: Majee SB (eds) Emerging concepts in analysis and applications of hydrogels.. Rijeka: IntechOpen. https://doi.org/10.5772/64301

  5. Hoare TR, Kohane DS (2008)Hydrogels in drug delivery: progress and challenges. Polymer 49(8):1993–2007. Available from: https://www.sciencedirect.com/science/article/pii/S0032386108000487

  6. Jacob S, Nair AB, Shah J, Sreeharsha N, Gupta S, Shinu P (2021) Emerging role of hydrogels in drug delivery systems, tissue engineering and wound management. Pharmaceutics13(3). Available from: https://doi.org/10.3390/pharmaceutics13030357

  7. Basso J, Miranda A, Nunes S, Cova T, Sousa J, Vitorino C, et al. (2018) Hydrogel-based drug delivery nanosystems for the treatment of brain tumors. Gels4(3). Available from: https://doi.org/10.3390/gels4030062

  8. Caló E, Khutoryanskiy VV (2015) Biomedical applications of hydrogels: A review of patents and commercial products. Eur Polym J65:252–267. Available from: https://www.sciencedirect.com/science/article/pii/S0014305714004091

  9. Corrente F, Matricardi P, Paolicelli P, Tita B, Vitali F, Casadei MA (2009) Physical carboxymethylscleroglucan/calcium ion hydrogels as modified drug delivery systems in topical formulations. Molecules 14(8):2684–2698.https://doi.org/10.3390/molecules14082684

  10. Wichterle O, Lím D (1960) Hydrophilic gels for biological use. Nature 185(4706):117–118. Available from: https://www.nature.com/articles/185117a0

  11. Jonker AM, Löwik D (2012) Peptide-and protein-based hydrogels. Chemistry. Available from: https://pubs.acs.org/doi/abs/https://doi.org/10.1021/cm202640w

  12. Kopecek J (2007) Hydrogel biomaterials: a smart future? Biomaterials 28(34):5185–5192. https://doi.org/10.1016/j.biomaterials.2007.07.044

  13. Katyal P, Mahmoudinobar F, Montclare JK (2020) Recent trends in peptide and protein-based hydrogels. Curr Opin Struct Biol 63:97–105. https://doi.org/10.1016/j.sbi.2020.04.007

  14. Desai S, Harrison B (2010) Direct-writing of biomedia for drug delivery and tissue regeneration. In: Narayan R, Boland T, Lee YS (eds) Printed biomaterials: novel processing and modeling techniques for medicine and surgery. Springer, New York, p 71–89. https://doi.org/10.1007/978-1-4419-1395-1_5

  15. Wu Y, Antony S, Meitzler JL, Doroshow JH (2014) Molecular mechanisms underlying chronic inflammation-associated cancers. Cancer Lett 345(2):164–173. https://doi.org/10.1016/j.canlet.2013.08.014

  16. Tabas I, Glass CK (2013) Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339(6116):166–172. Available from: https://science.sciencemag.org/content/339/6116/166.abstract

  17. Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA et al (2009) Inflammatory disease processes and interactions with nutrition. Br J Nutr101(Suppl 1):S1–45. https://doi.org/10.1017/S0007114509377867

  18. Deng Z, Liu S (2021) Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases. Drug Deliv Transl Res. https://doi.org/10.1007/s13346-021-00977-8

  19. Frith JE, Cameron AR, Menzies DJ, Ghosh P, Whitehead DL, Gronthos S et al (2013) An injectable hydrogel incorporating mesenchymal precursor cells and pentosan polysulphate for intervertebral disc regeneration. Biomaterials. 34:9430–40. https://doi.org/10.1016/j.biomaterials.2013.08.072

  20. Seo BB, Koh JT, Song SC (2017) Tuning physical properties and BMP-2 release rates of injectable hydrogel systems for an optimal bone regeneration effect. Biomaterials 122:91–104. https://doi.org/10.1016/j.biomaterials.2017.01.016

  21. Tang G, Zhou B, Li F, Wang W, Liu Y, Wang X et al. (2020) Advances of naturally derived and synthetic hydrogels for intervertebral disk regeneration. Front Bioeng Biotechnol 8:745. https://doi.org/10.3389/fbioe.2020.00745

  22. Brovold M, Almeida JI, Pla-Palacín I, Sainz-Arnal P, Sánchez-Romero N, Rivas JJ et al (2018) Naturally-derived biomaterials for tissue engineering applications. Adv Exp Med Biol 1077:421–449. https://doi.org/10.1007/978-981-13-0947-2_23

  23. Ahmed EM (2015) Hydrogel: preparation, characterization, and applications: a review. J Advert Res 6(2):105–121. https://doi.org/10.1016/j.jare.2013.07.006

  24. Kumar AC, Erothu H (2016) Synthetic polymer hydrogels. Biomedical applications of polymeric. Available from: https://books.google.com/books?hl=en&lr=&id=YeIqDQAAQBAJ&oi=fnd&pg=PA141&dq=Kumar+A+C+Erothu+H+(2016)+Synthetic+Polymer+Hydrogels+Biomedical+Applications+of+Polymeric+Materials+and+Composites+141+162&ots=wCSmBQUmR5&sig=vFHpF4g6vXrGOjIQfPXQRJoU2Ns

  25. El-Sherbiny IM, Yacoub MH (2013) Hydrogel scaffolds for tissue engineering: progress and challenges. Glob Cardiol Sci Pract 2013(3):316–342. Available from: https://doi.org/10.5339/gcsp.2013.38

  26. Singhal R, Gupta K (2016) A review: tailor-made hydrogel structures (classifications and synthesis parameters). Polym Plast Technol Eng 55(1):54–70. https://doi.org/10.1080/03602559.2015.1050520

  27. Chang C, Zhang L (2011) Cellulose-based hydrogels: present status and application prospects. Carbohydr Polym 84(1):40–53. Available from: https://www.sciencedirect.com/science/article/pii/S0144861710010003

  28. Ahmadi F, Oveisi Z, Samani SM, Amoozgar Z (2015) Chitosan based hydrogels: characteristics and pharmaceutical applications. Res Pharm Sci 10(1):1–16. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26430453

  29. Catoira MC, Fusaro L, Di Francesco D, Ramella M, Boccafoschi F (2019) Overview of natural hydrogels for regenerative medicine applications. J Mater Sci Mater Med 30(10):115. https://doi.org/10.1007/s10856-019-6318-7

  30. Fernández-Pérez J, Ahearne M (2019) The impact of decellularization methods on extracellular matrix derived hydrogels. Sci Rep 9(1):14933. https://doi.org/10.1038/s41598-019-49575-2

  31. Freytes DO, Martin J, Velankar SS, Lee AS, Badylak SF (2008) Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix. Biomaterials 29(11):1630–1637. https://doi.org/10.1016/j.biomaterials.2007.12.014

  32. Singelyn JM, DeQuach JA, Seif-Naraghi SB, Littlefield RB, Schup-Magoffin PJ, Christman KL (2009) Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials 30(29):5409–5416. https://doi.org/10.1016/j.biomaterials.2009.06.045

  33. Travascio F (2016) Composition and function of the extracellular matrix in the human body. BoD—Books on Demand. Available from: https://play.google.com/store/books/details?id=bJ2RDwAAQBAJ

  34. Seif-Naraghi SB, Singelyn JM, Salvatore MA, Osborn KG, Wang JJ, Sampat U, et al () Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci Transl Med [Internet]. 2013 Feb 20;5(173):173ra25. Available from: https://doi.org/10.1126/scitranslmed.3005503

  35. Wassenaar JW, Gaetani R, Garcia JJ, Braden RL, Luo CG, Huang D, et al (2016) Evidence for mechanisms underlying the functional benefits of a myocardial matrix hydrogel for post-MI treatment. J Am Coll Cardiol 67(9):1074–1086. https://doi.org/10.1016/j.jacc.2015.12.035

  36. Saldin LT, Cramer MC, Velankar SS, White LJ, Badylak SF (2017) Extracellular matrix hydrogels from decellularized tissues: structure and function. Acta Biomater 49:1–15. https://doi.org/10.1016/j.actbio.2016.11.068

  37. Gagner JE, Kim W, Chaikof EL (2014) Designing protein-based biomaterials for medical applications. Acta Biomater 10(4):1542–57. Available from: https://www.sciencedirect.com/science/article/pii/S1742706113005072

  38. Krishna OD, Kiick KL (2010) Protein- and peptide-modified synthetic polymeric biomaterials. Biopolymers 94(1):32–48. https://doi.org/10.1002/bip.21333

  39. Sengupta D, Heilshorn SC (2010) Protein-engineered biomaterials: highly tunable tissue engineering scaffolds. Tissue Eng Part B Rev 16(3):285–93. https://doi.org/10.1089/ten.teb.2009.0591

  40. Wang X, Kim HJ, Wong C, Vepari C, Matsumoto A, Kaplan DL (2006) Fibrous proteins and tissue engineering. Materials Today 9:44–53. Available from: https://doi.org/10.1016/s1369-7021(06)71742-4

  41. Karsdal MA, Nielsen MJ, Sand JM, Henriksen K, Genovese F, Bay-Jensen AC et al (2013) Extracellular matrix remodeling: the common denominator in connective tissue diseases possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure vol 11, ASSAY and drug development technologies, pp 70–92. https://doi.org/10.1089/adt.2012.474

  42. Heymer A, Haddad D, Weber M, Gbureck U, Jakob PM, Eulert J et al (2008) Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. Biomaterials 29(10):1473–1483. https://doi.org/10.1016/j.biomaterials.2007.12.003

  43. Phillips JB (2014) Building stable anisotropic tissues using cellular collagen gels. Organogenesis 10(1):6–8. https://doi.org/10.4161/org.27487

  44. Plant AL, Bhadriraju K, Spurlin TA, Elliott JT (2009) Cell response to matrix mechanics: focus on collagen. Biochim Biophys Acta 1793(5):893–902. https://doi.org/10.1016/j.bbamcr.2008.10.012

  45. Placzek M (2008) Tissue recombinations in collagen gels. Methods Mol Biol 461:325–35. https://doi.org/10.1007/978-1-60327-483-8_23

  46. Patel ZS, Ueda H, Yamamoto M, Tabata Y, Mikos AG (2008) In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res 25(10):2370–2378. https://doi.org/10.1007/s11095-008-9685-1

  47. Kimura Y, Tabata Y (2010) Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed 21(1):37–51. https://doi.org/10.1163/156856209X410193

  48. Konishi M, Tabata Y, Kariya M, Suzuki A, Mandai M, Nanbu K et al (2003) In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. J Control Release 92(3):301–313. https://doi.org/10.1016/s0168-3659(03)00364-x

  49. Rattanaruengsrikul V, Pimpha N, Supaphol P (2012) In vitro efficacy and toxicology evaluation of silver nanoparticle-loaded gelatin hydrogel pads as antibacterial wound dressings. J Appl Polym Sci 124:1668–82. https://doi.org/10.1002/app.35195

  50. Stevens KR, Einerson NJ, Burmania JA, Kao WJ (2002) In vivo biocompatibility of gelatin-based hydrogels and interpenetrating networks. J Biomater Sci Polym Ed 13(12):1353–1366. https://doi.org/10.1163/15685620260449741

  51. Yamamoto M, Ikada Y, Tabata Y (2001) Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed 12(1):77–88. https://doi.org/10.1163/156856201744461

  52. Asmani MN, Ai J, Amoabediny G, Noroozi A, Azami M, Ebrahimi-Barough S et al. (2013) Three-dimensional culture of differentiated endometrial stromal cells to oligodendrocyte progenitor cells (OPCs) in fibrin hydrogel. Cell Biol Int 37(12):1340–9. https://doi.org/10.1002/cbin.10171

  53. des Rieux A, Shikanov A, Shea LD (2009) Fibrin hydrogels for non-viral vector delivery in vitro. J Control Release 136(2):148–54. Available from: https://www.sciencedirect.com/science/article/pii/S0168365909000935

  54. Gamboa-Martínez TC, Luque-Guillén V, González-García C, Ribelles JLG, Gallego-Ferrer G (2015) Crosslinked fibrin gels for tissue engineering: two approaches to improve their properties. J Biomed Mater Res Part A. 103:614–621. https://doi.org/10.1002/jbm.a.35210

  55. Guthold M, Liu W, Sparks EA, Jawerth LM, Peng L, Falvo M, et al (2007) A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers. Cell Biochem Biophys 49(3):165–181. https://doi.org/10.1007/s12013-007-9001-4

  56. Lei P, Padmashali RM, Andreadis ST (2009) Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels. Biomaterials 30(22):3790–3799. https://doi.org/10.1016/j.biomaterials.2009.03.049

  57. Fathi A, Mithieux SM, Wei H, Chrzanowski W, Valtchev P, Weiss AS et al (2014) Elastin based cell-laden injectable hydrogels with tunable gelation, mechanical and biodegradation properties. Biomaterials 35(21):5425–5435. https://doi.org/10.1016/j.biomaterials.2014.03.026

  58. Lim DW, Nettles DL, Setton LA, Chilkoti A (2008) In situ cross-linking of elastin-like polypeptide block copolymers for tissue repair. Biomacromolecules 9(1):222–230. https://doi.org/10.1021/bm7007982

  59. McHale MK, Setton LA, Chilkoti A (2005) Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng 11(11–12):1768–1779. https://doi.org/10.1089/ten.2005.11.1768

  60. Tomita N, Morita Y, Hattori K, Harada Y (2003) Culture of chondrocytes in fibroin–hydrogel sponge and engineering. Available from: https://content.iospress.com/articles/bio-medical-materials-and-engineering/bme264

  61. Bose S, Bandyopadhyay A (2016) Materials and devices for bone disorders. Academic Press. Available from: https://play.google.com/store/books/details?id=8U7pCAAAQBAJ

  62. Singh TRR, Laverty G, Donnelly R (2018) Hydrogels: design, synthesis and application in drug delivery and regenerative medicine. CRC Press. Available from: https://play.google.com/store/books/details?id=NGpQDwAAQBAJ

  63. Fini M, Motta A, Torricelli P, Giavaresi G, Nicoli Aldini N, Tschon M et al (2005) The healing of confined critical size cancellous defects in the presence of silk fibroin hydroge. Biomaterials. 26: 3527–36. https://doi.org/10.1016/j.biomaterials.2004.09.040

  64. Eissa AS, Khan SA (2005) Acid-induced Gelation of enzymatically modified, preheated whey proteins. J Agric Food Chem 53: 5010–7. https://doi.org/10.1021/jf047957w

  65. Gunasekaran S, Ko S, Xiao L (2007) Use of whey proteins for encapsulation and controlled delivery applications. J Food Eng 83:31–40. https://doi.org/10.1016/j.jfoodeng.2006.11.001

  66. Ustunol Z (2014) Applied food protein chemistry. John Wiley & Sons. Available from: https://play.google.com/store/books/details?id=haNsDwAAQBAJ

  67. Prasad PN (2012) Frontiers of polymers and advanced materials. Springer US. Available from: https://play.google.com/store/books/details?id=9w-pmQEACAAJ

  68. Reddy N, Aramwit P (2021) Sustainable uses of byproducts from silk processing. John Wiley & Sons. Available from: https://play.google.com/store/books/details?id=HXUrEAAAQBAJ

  69. Wang Z, Zhang Y, Zhang J, Huang L, Liu J, Li Y, et al (2015) Exploring natural silk protein sericin for regenerative medicine: an injectable, photoluminescent, cell-adhesive 3D hydrogel. Sci Rep , 4. https://doi.org/10.1038/srep07064

  70. Liu C, Zhang Q, Zhu S, Liu H, Chen J (2019) Preparation and applications of peptide-based injectable hydrogels. RSC Adv 9(48):28299–282311. Available from: https://pubs.rsc.org/fa/content/articlehtml/2019/ra/c9ra05934b

  71. Zhou J, Li J, Du X, Xu B (2017) Supramolecular biofunctional materials. Biomaterials 129:1–27. https://doi.org/10.1016/j.biomaterials.2017.03.014

  72. Serizawa T, Fukuta H, Date T, Sawada T (2016) Affinity-based release of polymer-binding peptides from hydrogels with the target segments of peptides. Chem Commun 52(11):2241–2244. https://doi.org/10.1039/c5cc09016d

  73. Burdick JA, Mauck RL (2010) Biomaterials for tissue engineering applications: a review of the past and future trends. Springer Science & Business Media. Available from: https://play.google.com/store/books/details?id=Zj6ubOFXGgUC

  74. Giglio ED, De Giglio E, Cometa S, Ricci MA, Cafagna D, Savino AM, et al (2011) Ciprofloxacin-modified electrosynthesized hydrogel coatings to prevent titanium-implant-associated infections, Acta Biomaterialia7:882–891. Available from: https://doi.org/10.1016/j.actbio.2010.07.030

  75. Marchesan S, Qu Y, Waddington LJ, Easton CD, Glattauer V, Lithgow TJ, et al () Self-assembly of ciprofloxacin and a tripeptide into an antimicrobial nanostructured hydrogel [Internet]. Vol. 34, Biomaterials. 2013. p. 3678–87. https://doi.org/10.1016/j.biomaterials.2013.01.096

  76. Li J, Xing R, Bai S, Yan X (2019) Recent advances of self-assembling peptide-based hydrogels for biomedical applications. Soft Matter 15(8):1704–1715. https://doi.org/10.1039/c8sm02573h

  77. Bamford KB (1999) Chronic gastrointestinal inflammation. FEMS Immunol Med Microbiol 24(2):161–168. https://doi.org/10.1111/j.1574-695X.1999.tb01277.x

  78. Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517. https://doi.org/10.1053/j.gastro.2004.01.063

  79. Kornbluth A, Sachar DB, and The Practice Parameters Committee of the American College of Gastroenterology (2010) Ulcerative colitis practice guidelines in adults: American College of gastroenterology, practice parameters committee. Official Journal of the American College of Gastroenterology | ACG 105(3):501. Available from: https://journals.lww.com/ajg/Fulltext/2010/03000/Ulcerative_Colitis_Practice_Guidelines_in_Adults_.6.aspx

  80. Ediger JP, Walker JR, Graff L, Lix L, Clara I, Rawsthorne P, et al (2007) Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 102(7):1417–1426. https://doi.org/10.1111/j.1572-0241.2007.01212.x

  81. Zhang S, Ermann J, Succi MD, Zhou A, Hamilton MJ, Cao B, et al (2015) An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease. Sci Transl Med 7(300):300ra128. https://doi.org/10.1126/scitranslmed.aaa5657

  82. Araki T, Mitsuyama K, Yamasaki H, Morita M, Tsuruta K, Mori A, et al (2021) Therapeutic potential of a self-assembling peptide hydrogel to treat colonic injuries associated with inflammatory bowel disease. J Crohns Colitis. https://doi.org/10.1093/ecco-jcc/jjab033

  83. Cao X, Duan L, Hou H, Liu Y, Chen S, Zhang S, et al (2020) IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization. Theranostics 10(17):7697–7709. https://doi.org/10.7150/thno.45434

  84. Hong L, Chen G, Cai Z, Liu H, Zhang C, Wang F, et al (2022) Balancing microthrombosis and inflammation via injectable protein hydrogel for inflammatory bowel disease. Adv Sci 9(20):e2200281. https://doi.org/10.1002/advs.202200281

  85. Singhal P, Vashisht H, Nisar S, Mehra S, Rattan S (2022) Stimulus responsive soy-protein based hydrogels through grafting HEMA for biomedical applications. Ind Crops Prod 178:114621. Available from: https://www.sciencedirect.com/science/article/pii/S0926669022001042

  86. Cheng Z, Qing R, Hao S, Ding Y, Yin H, Zha G, et al (2021) Fabrication of ulcer-adhesive oral keratin hydrogel for gastric ulcer healing in a rat. Regen Biomater 8(2):rbab008. https://doi.org/10.1093/rb/rbab008

  87. Nelson PT, Soma LA, Lavi E (2002) Microglia in diseases of the central nervous system. Ann Med 34(7–8):491–500. https://doi.org/10.1080/078538902321117698

  88. Nanoscaffold smart drug delivery system may help treatment for neurological disorders (2020). Available from: https://www.nanowerk.com/nanotechnology-news2/newsid=56178.php

  89. Fernandez-Serra R, Gallego R, Lozano P, González-Nieto D (2020) Hydrogels for neuroprotection and functional rewiring: a new era for brain engineering. Neural Regeneration Res 15(5):783–9. https://doi.org/10.4103/1673-5374.268891

  90. Xu J, Duan Z, Qi X, Ou Y, Guo X, Zi L, et al (2020) Injectable gelatin hydrogel suppresses inflammation and enhances functional recovery in a mouse model of intracerebral hemorrhage. Front Bioeng Biotechnol 8:785. https://doi.org/10.3389/fbioe.2020.00785

  91. Hekmatimoghaddam S, Iman M, Shahdadi Sardo H, Jebali A (2019) Gelatin hydrogel containing cerium oxide nanoparticles covered by interleukin-17 aptamar as an anti- inflammatory agent for brain inflammation. J Neuroimmunol 326:79–83. https://doi.org/10.1016/j.jneuroim.2018.11.011

  92. He J, Zhang N, Zhu Y, Jin R, Wu F (2021) MSC spheroids-loaded collagen hydrogels simultaneously promote neuronal differentiation and suppress inflammatory reaction through PI3K-Akt signaling pathway. Biomaterials 265:120448. https://doi.org/10.1016/j.biomaterials.2020.120448

  93. Shukla SK, Sharma AK, Gupta V, Yashavarddhan MH (2019) Pharmacological control of inflammation in wound healing. J Tissue Viability 28(4):218–22. https://doi.org/10.1016/j.jtv.2019.09.002

  94. Wu DQ, Zhu J, Han H, Zhang JZ, Wu FF, Qin XH, et al (2018) Synthesis and characterization of arginine-NIPAAm hybrid hydrogel as wound dressing: In vitro and in vivo study. Acta Biomater 65:305–316. https://doi.org/10.1016/j.actbio.2017.08.048

  95. Gupta A, Kowalczuk M, Heaselgrave W, Britland ST, Martin C, Radecka I (2019) The production and application of hydrogels for wound management: a review. Eur Polym J 111:134–151. Available from: https://www.sciencedirect.com/science/article/pii/S0014305718318317

  96. Kang JI, Park KM (2021) Advances in gelatin-based hydrogels for wound management. J Mater Chem B Mater Biol Med 9(6):1503–1520. https://doi.org/10.1039/d0tb02582h

  97. Zhao CC, Zhu L, Wu Z, Yang R, Xu N, Liang L (2020) Resveratrol-loaded peptide-hydrogels inhibit scar formation in wound healing through suppressing inflammation. Regen Biomater 7(1):99–107. https://doi.org/10.1093/rb/rbz041

  98. Sonamuthu J, Cai Y, Liu H, Kasim MSM, Vasanthakumar VR, Pandi B, et al (2020) MMP-9 responsive dipeptide-tempted natural protein hydrogel-based wound dressings for accelerated healing action of infected diabetic wound. Int J Biol Macromol 153:1058–69. https://doi.org/10.1016/j.ijbiomac.2019.10.236

  99. Dong Y, A S, Rodrigues M, Li X, Kwon SH, Kosaric N, et al (2017) Injectable and tunable gelatin hydrogels enhance stem cell retention and improve cutaneous wound healing. Adv Funct Mater 27(24):1606619. https://doi.org/10.1002/adfm.201606619

  100. Cheng L, Cai Z, Ye T, Yu X, Chen Z, Yan Y, et al (2020) Injectable polypeptide‐protein hydrogels for promoting infected wound healing. Adv Funct Mater, p 2001196. https://doi.org/10.1002/adfm.202001196

  101. Cui T, Li X, He S, Xu D, Yin L, Huang X, et al (2020) Instant Self-Assembly Peptide Hydrogel Encapsulation with Fibrous Alginate by Microfluidics for Infected Wound Healing. ACS Biomater Sci Eng 6(9):5001–5011. https://doi.org/10.1021/acsbiomaterials.0c00581

  102. Gueler F, Gwinner W, Schwarz A, Haller H (2004) Long-term effects of acute ischemia and reperfusion injury. Kidney Int66(2):523–527. https://doi.org/10.1111/j.1523-1755.2004.761_11.x

  103. Lutz J, Thürmel K, Heemann U (2010) Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm7:27. https://doi.org/10.1186/1476-9255-7-27

  104. Chen S, Liu S, Zhang L, Han Q, Liu H, Shen J, et al (2020) Construction of injectable silk fibroin/polydopamine hydrogel for treatment of spinal cord injury. Chem Eng J399:125795. https://www.sciencedirect.com/science/article/pii/S1385894720319239

  105. Lu HD, Charati MB, Kim IL, Burdick JA (2012) Injectable shear-thinning hydrogels engineered with a self-assembling Dock-and-Lock mechanism. Biomaterials33(7):2145–2153. https://doi.org/10.1016/j.biomaterials.2011.11.076

  106. Libby P (2006) Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr83(2):456S–460S. https://doi.org/10.1093/ajcn/83.2.456S

  107. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med352(16):1685–1695. https://doi.org/10.1056/NEJMra043430

  108. Lawler PR, Bhatt DL, Godoy LC, Lüscher TF, Bonow RO, Verma S, et al (2021) Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J42(1):113–131. https://doi.org/10.1093/eurheartj/ehaa099

  109. Peppas NA, Hilt JZ, Khademhosseini A, Langer R (2006) Hydrogels in biology and medicine: From molecular principles to bionanotechnology. Adv Mater18(11):1345–1360. https://doi.org/10.1002/adma.200501612

  110. Moon JJ, Saik JE, Poché RA, Leslie-Barbick JE, Lee SH, Smith AA, et al (2010) Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 31(14):3840–3847. https://doi.org/10.1016/j.biomaterials.2010.01.104

  111. Seliktar D (2010) Designing cell-compatible hydrogels for biomedical applications. Science 336(6085):1124–1128. https://doi.org/10.1126/science.1214804

  112. Van Vlierberghe S, Dubruel P, Schacht E (2011) Biopolymer-based hydrogels as scaffolds for tissue engineering applications: a review. Biomacromolecules12(5):1387–1408. https://doi.org/10.1021/bm200083n

  113. Cai H, Wu FY, Wang QL, Xu P, Mou FF, Shao SJ, et al (2019) Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction. FASEB J33(7):8306–8320. https://doi.org/10.1096/fj.201801768RR

  114. Reis LA, Chiu LLY, Wu J, Feric N, Laschinger C, Momen A, et al (2015) Hydrogels With Integrin-Binding Angiopoietin-1–Derived Peptide, QHREDGS, for Treatment of Acute Myocardial Infarction. Circ Heart Fail 8(2):333–341. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001881

  115. Firoozi S, Pahlavan S, Ghanian MH, Rabbani S, Tavakol S, Barekat M, et al (2020) A Cell-Free SDKP-Conjugated Self-Assembling Peptide Hydrogel Sufficient for Improvement of Myocardial Infarction. Biomolecules10(2). https://doi.org/10.3390/biom10020205

  116. Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al (2018) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9(6):7204–7218. https://doi.org/10.18632/oncotarget.23208

  117. La Manna S, Di Natale C, Florio D, Marasco D (2018) Peptides as Therapeutic Agents for Inflammatory-Related Diseases. Int J Mol Sci 19(9). https://doi.org/10.3390/ijms19092714

  118. Todoric J, Antonucci L, Karin M (2016) Targeting Inflammation in Cancer Prevention and Therapy. Cancer Prev Res9(12):895–905. https://doi.org/10.1158/1940-6207.CAPR-16-0209

  119. Gregory A (2018) Self-assembling peptide hydrogel for local anticancer prodrug delivery in the treatment of glioblastoma multiforme. Clemson University. Available from: https://tigerprints.clemson.edu/all_theses/2941/

  120. Gangrade A, Mandal BB (2019) Injectable carbon nanotube impregnated silk based multifunctional hydrogel for localized targeted and on-demand anticancer drug delivery. ACS Biomater Sci Eng 5(5):2365–2381. https://doi.org/10.1021/acsbiomaterials.9b00416

  121. Yang L, Zhang C, Ren C, Liu J, Zhang Y, Wang J, et al (2019) Supramolecular hydrogel based on chlorambucil and peptide drug for cancer combination therapy. ACS Appl Mater Interfaces 11(1):331–339. https://doi.org/10.1021/acsami.8b18425

  122. Mandal A, Clegg JR, Anselmo AC, Mitragotri S (2020) Hydrogels in the clinic. Bioeng Transl Med 5(2):e10158. https://doi.org/10.1002/btm2.10158

  123. Sharpe LA, Daily AM, Horava SD, Peppas NA (2014) Therapeutic applications of hydrogels in oral drug delivery. Expert Opin Drug Deliv 11(6):901–915. https://doi.org/10.1517/17425247.2014.902047

  124. Madl CM, Heilshorn SC (2017) Tyrosine-selective functionalization for bio-orthogonal cross-linking of engineered protein hydrogels. Bioconjug Chem 28(3):724–730. https://doi.org/10.1021/acs.bioconjchem.6b00720

  125. Vijayavenkataraman S, Yan WC, Lu WF, Wang CH, Fuh JYH (2018) 3D bioprinting of tissues and organs for regenerative medicine. Adv Drug Deliv Rev 132:296–332. https://doi.org/10.1016/j.addr.2018.07.004

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Biotechnology, School of Bioengineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, 603 203, India

    X. Janet Bertilla & S. Rupachandra

Authors
  1. X. Janet Bertilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Rupachandra
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the conceptualization of the article. The literature search and the final draft of the manuscript were carried out by JB. The outline draft of the review was prepared by SR.

Corresponding author

Correspondence to S. Rupachandra.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare that are relevant to the content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bertilla, X.J., Rupachandra, S. Insights into current directions of protein and peptide-based hydrogel drug delivery systems for inflammation. Polym. Bull. 80, 9409–9436 (2023). https://doi.org/10.1007/s00289-022-04527-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00289-022-04527-1

Keywords

Search

Navigation